Fox Run Management, L.L.C. Evolus, Inc. Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$7.6 - $10.53 $144,369 - $200,027	18,996 New	18,996 $200,000
Q4 2022 Feb 07, 2023	BUY	$6.52 - $8.95 $70,833 - $97,232	10,864 New	10,864 $81,000
Q4 2021 Feb 09, 2022	SELL	$5.37 - $8.38 $55,525 - $86,649	-10,340 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $76,102 - $141,347	10,340 New	10,340 $79,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.